Viatris Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Viatris in the last twelve months. There are currently 2 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Viatris stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VTRS, but not buy additional shares or sell existing shares.
View analyst ratings for Viatris or view top-rated stocks.

5 analysts have issued 1-year target prices for Viatris' stock. Their VTRS stock forecasts range from $9.00 to $19.00. On average, they expect Viatris' share price to reach $12.40 in the next twelve months. This suggests a possible upside of 13.1% from the stock's current price.
View analysts' price targets for Viatris or view top-rated stocks among Wall Street analysts.

Viatris' stock was trading at $13.53 at the beginning of 2022. Since then, VTRS shares have decreased by 19.0% and is now trading at $10.96.
View the best growth stocks for 2022 here.

Viatris is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Viatris.

Viatris Inc. (NASDAQ:VTRS) released its quarterly earnings results on Monday, May, 9th. The company reported $0.33 earnings per share for the quarter, missing analysts' consensus estimates of $0.83 by $0.50. The business had revenue of $4.19 billion for the quarter, compared to analysts' expectations of $4.26 billion. Viatris had a net margin of 0.95% and a trailing twelve-month return on equity of 21.50%. The firm's revenue for the quarter was down 5.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.92 EPS.
View Viatris' earnings history.

Viatris announced a quarterly dividend on Monday, May 9th. Shareholders of record on Tuesday, May 24th will be paid a dividend of $0.12 per share on Thursday, June 16th. This represents a $0.48 annualized dividend and a dividend yield of 4.38%. The ex-dividend date is Monday, May 23rd.
View Viatris' dividend history.

Viatris(NASDAQ:VTRS) pays an annual dividend of $0.48 per share and currently has a dividend yield of 4.38%. VTRS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Viatris is 342.86%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, Viatris will have a dividend payout ratio of 14.16% next year. This indicates that Viatris will be able to sustain or increase its dividend.
View Viatris' dividend history.

Viatris declared that its board has authorized a share buyback plan on Monday, February 28th 2022, which authorizes the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 7.5% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its shares are undervalued.

Viatris updated its FY 2022 earnings guidance on Monday, June, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $17.00 billion-$17.50 billion, compared to the consensus revenue estimate of $17.24 billion.

8 employees have rated Viatris CEO Michael Goettler on Glassdoor.com. Michael Goettler has an approval rating of 85% among Viatris' employees.

Some companies that are related to Viatris include Takeda Pharmaceutical (TAK), Astellas Pharma (ALPMY), Royalty Pharma (RPRX), MERCK Kommanditgesellschaft auf Aktien (MKGAF), Takeda Pharmaceutical (TKPYY), Genmab A/S (GMAB), Genmab A/S (GNMSF), Catalent (CTLT), Horizon Therapeutics Public (HZNP), BeiGene (BGNE), Alnylam Pharmaceuticals (ALNY), UCB (UCBJF), BioMarin Pharmaceutical (BMRN), Shiseido (SSDOY) and Ono Pharmaceutical (OPHLF).
View all of VTRS's competitors.

Viatris trades on the NASDAQ under the ticker symbol "VTRS."

Viatris' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.41%), BlackRock Inc. (7.28%), State Street Corp (4.67%), Deerfield Management Company L.P. Series C (1.71%), Invesco Ltd. (1.23%) and Northern Trust Corp (1.02%). Company insiders that own Viatris stock include James M Kilts, Menassie Taddese, Michael Goettler, Robert J Coury and W Don Cornwell.
View institutional ownership trends for Viatris.

VTRS stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Bank of Montreal Can, Bank of New York Mellon Corp, National Pension Service, Monaco Asset Management SAM, Sumitomo Mitsui Trust Holdings Inc., US Bancorp DE, and UBS Group AG. Company insiders that have sold Viatris company stock in the last two years include Menassie Taddese, and Robert J Coury.
View insider buying and selling activity for Viatris or view top insider-selling stocks.

VTRS stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Pacer Advisors Inc., State Street Corp, Arrowstreet Capital Limited Partnership, Invesco Ltd., Bank of Nova Scotia, BlackRock Inc., and Renaissance Technologies LLC. Company insiders that have bought Viatris stock in the last two years include James M Kilts, Michael Goettler, and W Don Cornwell.
View insider buying and selling activity for Viatris or or view top insider-buying stocks.

Shares of VTRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VTRS stock can currently be purchased for approximately $10.96.

Viatris (NASDAQ:VTRS) has a market capitalization of $13.29 billion and generates $17.89 billion in revenue each year. The company earns $-1.27 billion in net income (profit) each year or $0.14 on an earnings per share basis.

Viatris employs 37,000 workers across the globe.

Viatris' mailing address is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. The official website for Viatris is www.viatris.com. The company can be reached via phone at (724) 514-1800, via email at [email protected], or via fax at 724-514-1870.